Repligen
RGEN
#2040
Rank
โ‚น839.20 B
Marketcap
โ‚น14,908
Share price
-0.46%
Change (1 day)
18.05%
Change (1 year)
Categories

Repligen (RGEN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น75.60 Billion

According to Repligen 's latest financial reports the company's total liabilities are โ‚น75.60 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Repligen - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น73.51 B1.93%
2023-12-31โ‚น72.12 B40.37%
2022-12-31โ‚น51.37 B13.48%
2021-12-31โ‚น45.27 B65.64%
2020-12-31โ‚น27.33 B12.62%
2019-12-31โ‚น24.27 B118.23%
2018-12-31โ‚น11.12 B14.61%
2017-12-31โ‚น9.70 B18.85%
2016-12-31โ‚น8.16 B423.06%
2015-12-31โ‚น1.56 B48.72%
2014-12-31โ‚น1.04 B15.11%
2013-12-31โ‚น0.91 B29.24%
2012-12-31โ‚น0.70 B
2011-03-31โ‚น0.23 B-2.07%
2010-03-31โ‚น0.23 B0.97%
2009-03-31โ‚น0.23 B23.42%
2008-03-31โ‚น0.18 B24.18%
2007-03-31โ‚น0.15 B7.59%
2006-03-31โ‚น0.14 B-1.61%
2005-03-31โ‚น0.14 B35.72%
2004-03-31โ‚น0.10 B-0.37%
2003-03-31โ‚น0.10 B-18.04%
2002-03-31โ‚น0.13 B122.07%
2001-03-31โ‚น58.62 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novavax
NVAX
โ‚น120.21 B 59.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น140.14 B 85.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น113.51 B 50.14%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น9.823 T 12,892.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น4.664 T 6,069.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น7.041 T 9,213.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น10.400 T 13,655.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น50.39 B-33.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น7.41 B-90.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
โ‚น365.42 B 383.33%๐Ÿ‡บ๐Ÿ‡ธ USA